Atara Biotherapeutics Inc — Cash Flow (NASDAQ:ATRA) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 180.76 M220.52 M270.43 M192.98 M68.72 M 69.71 M Cash from investing activities 120.73 M22.26 M202.96 M123.87 M8.62 M 13.08 M Cash from financing activities 427.57 M103.94 M53.08 M2.01 M59.28 M 15.77 M Free cash flow 176.25 M209.94 M266.24 M191.75 M68.47 M 69.62 M

Nachrichten

Atara extends $9M milestone payment deadline to 2028

Atara Bio: Director James Huang verkauft Aktien im Wert von 489.000 US-Dollar

Atara Bio director Huang James sells $489k in shares

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.17%

FDA lehnt Zulassungsantrag für Ataras Tabelecleucel überraschend ab

FDA rejects Atara’s tabelecleucel application in surprise reversal

Atara Biotherapeutics: Aktie stürzt nach Ablehnung von Krebstherapie durch FDA ab

Atara Biotherapeutics stock plunges after FDA rejects cancer therapy

Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Atara Biotherapeutics (NASDAQ:ATRA), Day One Biopharmaceutical (NASDAQ:DAWN)

Why Is Atara Biotherapeutics Stock Sinking Monday? - Atara Biotherapeutics (NASDAQ:ATRA)

US Stocks Lower; Dow Tumbles Over 250 Points - Atara Biotherapeutics (NASDAQ:ATRA), Envirotech Vehicles (NASDAQ:EVTV)

Atara Biotherapeutics: An Empty Pipeline With Little Gas (NASDAQ:ATRA)